Asahi Kasei Medical is planning to buy ThermoGenesis' CryoSeal Fibrin Sealant system wound care product line for $2m in cash. ThermoGenesis chief executive officer Matthew Plavan said the transaction is the culmination of the company's ...
Tags: Asahi Kasei, ThermoGenesis, CryoSeal Fibrin Sealant system, wound care